Details
Category: Volume 06 Issue 12 December 2018
Hits: 1251

Title: Bisphenol-A Levels in Obese and Lean Polycystic Ovarian Syndrome (PCOS) Patients

Authors: Dr Shashank Nunna, Dr Mala Dharmalingam

 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.70

Abstract

Introduction

Endocrine disrupting chemicals and human health

Endocrine disrupting chemicals, are known as ‘‘endocrine disruptors’’ EDs, are defined by the Environmental Protection Agency as ‘‘exogenous agents that interfere with the synthesis, secretion, transport, metabolism, binding action or elimination of natural blood borne hormones that are present in the body and are responsible for homeostasis, reproduction, and developmental processes’’[1,2].

References

  1. Ribeiro E, Ladeira C, Viegas S. EDCs Mixtures: A Stealthy Hazard for Human Health Toxics. 2017 Feb 7;5(1). pii: E5.
  2. Diamanti-Kandarakis E, Bourguignon JP, Giudice LC, Hauser R, Prins GS, Soto AM, Zoeller RT, Gore AC. Endocrine-disrupting chemicals: an Endocrine Society scientific statement. Endocr Rev. 2009 Jun;30(4):293-342.
  3. Wei Zhou, Fang Fang, Wenting Zhu, Zi-Jiang Chen, Yanzhi Du, and Jun Zhang. Bisphenol A and Ovarian Reserve among Infertile Women with Polycystic Ovarian Syndrome. Int J Environ Res Public Health. 2017 Jan; 14(1): 18.
  4. Rogers JA, Metz L, Yong VW. Review: Endocrine disrupting chemicals and immune responses: a focus on bisphenol-A and its potential mechanisms. Mol Immunol. 2013 Apr;53(4):421-30.
  5. Palioura E, Kandaraki E, Diamanti-Kandarakis E. Endocrine disruptors and polycystic ovary syndrome: a focus on Bisphenol A and its potential pathophysi-ological aspects. Horm Mol Biol Clin Investig. 2014 Mar;17(3):137-44.
  6. Ben Maamar Met al;An investigation of the endocrine disruptive effects of bisphenol a in human and rat fetal testes. PLoS One. 2015 Feb 23;10(2):e0117226.
  7. Beena Joshi, Srabani Mukherjee, Anushree Patil, AmeyaPurandare, Sanjay Chauhan, Rama Vaidya. A cross-sectional study of polycystic ovarian syndrome among adolescent and young girls in Mumbai, India. Indian J Endocrinol Metab. 2014 May-Jun; 18(3): 317–324.
  8. Chen X, Yang D, Mo Y, Li L, Chen Y, Huang Y. Prevalence of polycystic ovary syndrome in unselected women from southern China. Eur J Obstet Gynecol Reprod Biol. 2008; 139:59–64.
  9. Li R, Zhang Q, Yang D, Li S, Lu S, Wu X, et al. Prevalence of polycystic ovary syndrome in women in China: A large community-based study. Hum Reprod. 2013;28:2562–9
  10. Kumarapeli V, Seneviratne R de A, Wijeyaratne CN, Yapa RM, Dodampahala SH. A simple screening approach for assessing community prevalence and phenotypes of polycystic ovary syndrome in semiurban population in Srilanka. Am J Epidemiol. 2008;168:321–7.
  11. Nidhi R, Padmalatha V, Nagarathna R, Amritanshu R. Prevalence of polycystic ovarian syndrome in Indian adolescents. J PediatrAdolesc Gynecol. 2011;24:223–7
  12. Nair MK, Pappachan P, Balakrishnan S, Leena ML, George B, Russell PS. Menstrual irregularity and poly cystic ovarian syndrome among adolescent girls: A two year follow-up study. Indian J Pediatr. 2012;79(Suppl 1):S69–73
  13. Gainie MA, Kalra S. Polycystic ovary syndrome A metabolic malady, the mother of all lifestyle disorders in women Can Indian health budget tackle it in future? Indian J Endocrinol Metab2011;15:239-41
  14. Papachroni KK, Piperi C, Levidou G, Korkolopoulou P, Pawelczyk L, Diamanti-Kandarakis E, Papavassiliou AG 2010 Lysyl oxidase interacts with AGEs signaling to modulate collagen synthesis in polycystic ovarian tissue. J Cell Mol Med 14:2460–2469
  15. Fernandez M, Bourguignon N, Lux-Lantos V, Libertun C 2010 Neonatal exposure to  bisphenol A and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats  Environ Health Perspect 118:1217–1222
  16. Takeuchi T, Tsutsumi O, Ikezuki Y, Kamei Y, Osuga Y, Fujiwara T, Takai Y, Momoeda M, Yano T, TaketaniY2006 Elevated serum bisphenol A levels under hyperandrogenic conditions may be caused by decreased UDP-glucuronosyl-transferase activity. Endocr J 53: 485–491
  17. Pugeat M, Crave JC, Tourniaire J, Forest MG 1996 Clinical utility of sex hormone-binding globulin measurement. Horm Res 45:148– 155
  18. De´chaud H, Ravard C, Claustrat F, de la Perrie`re AB, Pugeat M 1999 Xenoestrogen interaction with human sex hormone-binding globulin (hSHBG). Steroids 64:328–334
  19. Hanioka N, Jinno H, Nishimura T, Ando M 1998 Suppression of male-specific cytochrome P450 isoforms by bisphenol A in rat liver. Arch Toxicol 72:387–394
  20. Zhou W, Liu J, Liao L, Han S, Liu J 2008 Effect of Bisphenol A on steroid hormone production in rat ovarian theca-interstitial and granulosa cells. Mol Cell Endocrin 283:12–18
  21. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y 2004 Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 51:165–169
  22. Nelson VL, Qin Kn KN, Rosenfield RL, Wood JR, Penning TM, Legro RS, Strauss 3rd JF, McAllisterJM2001 The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab 86:5925–5933
  23. Kiddy DS, Sharp PS, White DM, Scanlon MF, Mason HD, Bray CS, Polson DW, Reed MJ, Franks S Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases. Clin Endocrinol (Oxf)32(2):213-20.
  24. Banaszewska B, Spaczyński RZ, Pelesz M, Pawelczyk L. Incidence of elevated LH/FSH ratio in polycystic ovary syndrome women with normo- and hyperinsulinemia. RoczAkad Med Bialymst. 2003;48:131-4.
  25. Alonso-Magdalena P, Morimoto S, Ripoll C, Fuentes E, Nadal A 2006 The estrogenic effect of bisphenol-A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114:106–112
  26. Alonso-Magdalena P, Laribi O, Ropero AB, Fuentes E, Ripoll C, Soria B, Nadal A 2005 Low doses of bisphenol A and diethylstilbestrol impair Ca signals in pancreatic beta-cells through a non classical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect 113:969–977
  27. Newbold RR, Jefferson WN, Padilla-Banks E 2007 Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod Toxicol 24:253–258
  28. Fernandez M, Bourguignon N, Lux-Lantos V, Libertun C 2010 Neonatal exposure to bisphenol A and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Environ Health Perspect 118:1217–1222

Corresponding Author

Dr Mala Dharmalingam

Department of Endocrinology, Ramaiah Medical College, Bengaluru, Karnataka, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.